12 Important Updates For World Cancer Day
watercolor colorful world map

Today is World Cancer Day. The theme of this year’s observance is “Together, all our actions matter.”

The message supports the understanding that everyone can take steps — big or small — to reduce the worldwide cancer burden.

This goal may be even more important due to the impact the COVID-19 pandemic has had on cancer care.

“It appears quite certain that disruptions to cancer services in the past year will lead to diagnosis at later stages, which — in turn — will translate into higher cancer-related mortality,” Prof. Anil D’Cruz, president of Union for International Cancer Control and director of oncology at Apollo Hospitals in India, said in a press release. “Worse still, the wider economic impact of the pandemic on cancer care in all probability will be felt for many years to come, even in high-income countries. In low- and middle-income countries, the impact is unfathomable. However, it is heartening to see the incredible response of the cancer community to mitigate these consequences. … Their stories are inspiring and these organizations need all the support we can provide to keep doing their incredible work.”

Union for International Cancer Control created World Cancer Day in 2000.

Part of the effort focuses on healthy lifestyle choices, such as getting sufficient physical activity, following a healthy diet, protecting against sun exposure, limiting alcohol consumption and avoiding tobacco.

Other objectives include educating the public about the signs and symptoms of cancer to ensure early detection and treatment, encouraging elected representatives to commit ample resources to reduce cancer mortality, and increasing awareness that lifestyle behaviors can have a considerable effect on cancer risk.

In conjunction with World Cancer Day, Healio and HemOnc Today present the following updates that provide insights into strategies that could help reduce the global cancer burden.

  1. Adhering to the basic principles of a Mediterranean diet prevented disease progression among men with localized prostate cancer on active surveillance. Read more.
  2. A coalition of 76 cancer organizations released an open letter urging Americans to make cancer care a priority amid the COVID-19 pandemic, emphasizing the benefits of screening and timely treatment far outweigh the risks. Read more.
  3. Greater adherence to a diabetes risk-reduction diet appeared associated with increased OS among a cohort of breast cancer survivors. Read more.
  4. Obesity-associated cancers are an emergent problem among younger adults. Read more.
  5. Patients who underwent lung cancer screening had a significant reduction in mortality associated with the disease, although it came with the potential for overdiagnosis. Read more.
  6. A poor-quality diet appeared associated with an increased risk for early-onset, high-risk distal and rectal adenomas. Read more.
  7. Physical activity before and after breast cancer treatment appeared associated with significant reductions in recurrence and mortality rates among a cohort of patients with high-risk disease. Read more.
  8. An updated American Cancer Society guideline increases the amount of weekly physical activity recommended to reduce cancer risk. The guideline also suggested individuals reduce consumption of red and processed meat, sugar-sweetened beverages, processed foods and alcohol. Read more.
  9. Recreational physical activity appeared associated with improved survival outcomes among women with endometrial cancer. Read more.
  10. Cancer survivors often overestimate the quality of their diets, reporting a higher-than-actual intake of fruits, vegetables and whole grains. Read more.
  11. A healthy diet appeared associated with a decreased risk for prostate cancer. Read more.
  12. The risk for colorectal cancer increased with cigarette smoking. Read more.

Read the full article at Healio.

Artificial Kidney Could Supplant Dialysis, The Decades-Old Standard Treatment For Kidney Failure
Image of kidneys blue background

Ira Kurtz, MD, chief of Nephrology at UCLA Health, believes the kidney is the human body’s most fascinating organ — even smarter, he says, than the brain.

For Dr. Kurtz and his colleagues, the holy grail long has been the development of a wearable and an implantable artificial kidney to replace the cumbersome dialysis process that has been the standard treatment for renal failure since the 1950s.

Now, after a five-year collaboration between the US Kidney Research Corporation, the University of Arkansas and UCLA Health, Dr. Kurtz and a team of researchers are on the verge of achieving that goal with the introduction of an artificial kidney that can be worn inside a backpack. If things proceed as hoped, within a few years a similar device could be implanted in the body as an artificial organ.

In July 2019, U.S. nephrologists celebrated when then-President Donald Trump announced in an executive order that his administration wanted to transform the care for 37 million Americans suffering from kidney disease, which kills more people annually than most cancers.

“It made a major splash in the renal community because it was the first time kidney care had really reached that kind of level in the government,” Dr. Kurtz said.

With the U.S. government spending an estimated $114 billion in Medicare payments each year to care for patients with kidney disease, it seemed like a prudent move.

“The total amount the federal government spends on kidney care is approximately 20% of Medicare’s trillion a year budget,” Dr. Kurtz said. “It’s billions with a B. So this is one reason the federal government wants changes to be made. For the first time, all the forces started coming together. The government, universities, and industry-recognized we have to do something. We can’t continue managing patients the same way we have for 50 years or more. Everything we do is the same as when I was trained in the ’70s. There’s nothing new. It’s the same hemodialysis, the same peritoneal dialysis.”

The lack of progress over the years in treating people with kidney failure can be attributed, in part, to the characteristics that Dr. Kurtz finds most interesting about the organ. The kidneys act as a complex chemistry and biology lab – recognizing numerous substances (water, ions, and organic molecules) that need to be excreted in the urine, thereby keeping the blood chemistry relatively constant. That makes the human heart seem like a much simpler organ, “just a pump,” he said.

Read the full article at UCLA Health.

Same Technology Behind Pfizer COVID-19 Vaccine is Leading Researchers to Possible MS Breakthrough
Nurse's hand holding a syringe giving a vaccination to a patient

BioNTech, the German firm which together with Pfizer created one of the COVID-19 vaccines, says they have used the same technology to create a vaccine which delayed the onset and reduced the severity of multiple sclerosis (MS) in mice.

Clinical trials published in Science showed that not only was the progression of the disease halted, but some lost motor function was recovered in the mice.

Both jabs use a piece of genetic material called mRNA which trains your genes to encode for proteins optimally designed to fight against whichever disease they are programed to fight. In the case of the COVID-19 vaccine, it trains your cells to produce antibodies that destroy the virus before it can replicate.

In the case of MS, which is not a virus but rather a disorder of the autonomic immune system, the auto-antigen encoded within the mRNA helped the immune system tolerate specific MS-related proteins without compromising normal immune function.

This halted the progression of the disease, and even restored lost motor function in mice.

The mice weren’t carrying MS, but rather experimental autoimmune encephalomyelitis, which the authors of the study, conducted by the BioNTech CEO Ugur Sahin M.D. Ph.D., described as “represents clinically relevant mouse models of human MS.”

Currently incurable, around one million Americans live with the autoimmune disease that causes loss of certain motor functions and brain degeneration. The disease mistakenly targets cells in the protective myelin sheath that covers nerve cells in the brain and spinal cord.

Read the original article at Good News Network.

UCSD Developing Sticker that Functions as COVID Test on Masks
COVID Test on Blue Mask

By ABC7 News

UC San Diego researchers are developing a simple way to test for COVID-19 risk. The technology comes in the form of a sticker placed on the outside of your mask.

“This could have a really profound impact on the trajectory of the pandemic,” Jesse Jokerst, an associate professor at UC San Diego, told KGTV.

The test looks for the presence of a specific COVID-19 protease in people’s breath. As someone wears the sticker

(Image Credit – ABC7 News)

on the mask throughout the day, it collects droplets. “At the end of the day, you click a little blister pack, and if it changes color, that means that you might have been exposed to COVID and that you should seek out some additional testing,” Jokerst said.

The National Institutes of Health just gave UC San Diego $1.3 million to develop this sticker and assess its accuracy to enhance surveillance of the disease around the world.

The test uses a technique called “Colorimetric Detection,” similar to home-pregnancy test indicators. Jokerst likens it to a smoke alarm. The test won’t tell you exactly what’s going on, but it serves as a warning that you need to take further action for safety.

“That’s what we were trying to develop. It’s a device that could say, ‘Hey, today there’s an elevated risk, and everybody should seek some additional testing,'” Jokerst explained. This kind of color-based test has never been used for viral detection. Jokerst says that once the pandemic ends, these tests could still assess the risk of diseases like SARS and MERS.

Read the original article at ABC7 News

Stressed out? Blame bad technology

By Reuters

There is no question that we are all more dependent on technology than ever. So what happens when that tech does not work?

In the past, Emily Dreyfuss used an old-school strategy: She yelled.

When Amazon’s Alexa spat out wrong answers or misunderstood questions, Dreyfuss let the virtual assistant have it.

“I used her as a scapegoat for my feelings,” said Dreyfuss, a writer and editor for Harvard’s Shorenstein Center. “When you have a non-sentient and annoying device in your home, who isn’t doing what you want, I talked to her in not the nicest terms. And my husband ganged up on her, too.”

Tech frustrations like this have happened to all of us. Your wifi is always dropping out. Your passwords do not work. Your laptop crashes, and you lose everything you were working on. Just reading about those possibilities could be enough to raise your blood pressure.

Technology can damage our state of mind, and new research is bearing that out: Computer giant Dell Technologies, in partnership with neuroscience firm EMOTIV, put people through a gauntlet of bad tech experiences, and then measured their brainwaves to gauge their reactions.

Test subjects had trouble logging on, or had to navigate sluggish applications, or saw their spreadsheets crash.

“The moment people started using bad technology, we saw a doubling of their levels of stress,” said Olivier Oullier, EMOTIV’s president. “I was a bit surprised by that, because you rarely see those levels going so high. Tech stress had a lasting effect, Oullier added. “People don’t relax back into calmness quickly. It takes a long time.”

Company bottom lines have suffered along with the mental health of employees. Constant frustration with bad tech affects how staffers handle their daily workloads, especially younger workers. Gen Z and Millennial test subjects saw a whopping 30% productivity drop as a result.

“Bad experiences affect you regardless of computer literacy,” said Cile Montgomery, who leads customer experience initiatives for Dell. “But young people seem to be even more impacted, because they expect technology to work.”

Read the full article at Reuters.

The ‘Last Mile’ for COVID-19 Vaccines Could Be The Biggest Challenge Yet
Nurse's hand holding a syringe giving a vaccination to a patient

A race to develop a COVID-19 vaccine began almost the minute the coronavirus’s genetic makeup was revealed in January.

Already, two companies have announced that their vaccines appear safe and about 95 percent effective (SN: 11/18/20, SN: 11/16/20). Government regulators in the United Kingdom granted permission on December 2 for the emergency use of a vaccine made by the pharmaceutical company Pfizer and its German biotech partner BioNTech. The first doses could be delivered within days of the announcement. Emergency use authorization and even full approval of the vaccines are probably not far off in the United States and other countries.

But another race is just beginning. Ultimately, the vaccines won’t truly be successful until enough people have gotten them to stop the spread of the virus and prevent severe disease and death. And that will pose a logistical challenge unlike any other. In normal times, potential vaccines have only a 10 percent chance of making it from Phase II clinical trials — which test safety, dosing, and sometimes give hints about effectiveness — to approval within 10 years, researchers reported November 24 in the Annals of Internal Medicine. On average, it takes successful vaccines over four years to go from Phase II trials to full regulatory approval.

Eli Lilly requests emergency approval for its Covid-19 antibody treatment
Hand with a medical glove, working with a syringe and a bottle of medicine.

Drugmaker Eli Lilly said Wednesday that it has requested an emergency use authorization from the Food and Drug Administration for its Covid-19 monoclonal antibody treatment.

Lilly’s medication is similar to the Regeneron antibody treatment President Donald Trump received after his Covid-19 diagnosis. Regeneron has not yet applied for such an authorization.

Lilly’s request comes nearly a month after the company announced partial results from a trial of the drug, which suggested it could help keep patients with mild to moderate forms of the illness from progressing to a point where they would need to be hospitalized. Those trial results have not yet been published or peer-reviewed, however.

The company’s chief scientific officer, Dr. Daniel Skovronsky, said the company’s data “provide sufficient evidence” that the therapy “may be effective to treat COVID-19 in patients with a high risk for serious outcomes.”

Lilly’s drug is currently being studied in National Institutes of Health-sponsored clinical trials both as a treatment and for prevention in people who have been exposed.

If the FDA authorizes the treatment for emergency use, it would help physicians access the drug outside of clinical trials.

Lilly is already manufacturing the drug, and expects to have 100,000 doses available this month. The supply could reach as many as 1 million doses by the end of the year.

Continue on to  NBC News to read the complete article.

This HBCU is Determined to Help All Communities Properly Fight COVID-19
Morehouse School of Medicine brown building corner view

The U.S. Department of Health and Human Services’ (HSS) Office of Minority Health has selected the Morehouse School of Medicine, a highly successful HBCU, to receive a $40 million initiative to help suffering communities fight the devastations of COVID-19. The grant was received as part of the National Infrastructure of Mitigating the Impact of COVID-19 within Racial and Ethnic Communities (NIMIC), an organization designed to help communities of color to have the appropriate resources to combat COVID-19.

Though this partnership, NIMIC and the Morehouse School of Medicine will be teaming up to provide vulnerable communities across the country to obtain access to healthcare, social services, testing kits, training and education. Though the NIMIC has already been working with various organizations within the last few months on providing these resources, the partnership with Morehouse allows for the project to continue their work in a more advanced, efficient, and more widespread way.

“Underlying social determinants of health and disparate burdens of chronic medical conditions are contributing to worse COVID-19 related outcomes in minority and socially vulnerable communities,” NIMIC’s Assistant Secretary of Health, Brett P. Giroir stated in a press release. “This partnership with Morehouse School of Medicine is essential to improving our overall response…we are ready to advance our efforts to support our most affected communities.”

Wash & Wear Community Mask Project to Provide 100,000 Reusable Medline Facemasks in Chicago’s Hardest Hit Communities
Latina woman checking her cell phone while walking near home

Medline partnership with YMCA, Knowality, and Blue Cross and Blue Shield of Illinois to provide COVID-19 PPE in Black and Brown Communities

Medline, in collaboration with YMCA of Metropolitan Chicago, Knowality, and Blue Cross and Blue Shield of Illinois (BCBSIL), recently announced the creation of the “Wash and Wear Community Mask Project.” This production and distribution initiative will supply 100,000 reusable Medline facemasks to people living in underserved Chicago neighborhoods that are being disproportionately impacted by COVID-19.

The facemask giveaway comes soon after Medline committed $1 million to various non-profits supporting the Black Lives Matter movement.

All Illinoisans are required to wear a facemask in public when social distancing is not an option, yet Black and Brown communities in the city don’t always have access to PPE. Through this new initiative, facemasks were distributed at no charge to anyone who needed one in some of the city’s most vulnerable communities. The distribution in such neighborhoods as Auburn Gresham, Chatam, Englewood, Roseland, Rosemoor, Austin, Humboldt Park, North Lawndale, South Lawndale, Pilsen and High Ridge.

With masks in high demand, recipients of the Medline Reusable Mask can use and use it over time. The facemasks are made from the same fabric as medical scrubs and have been tested to withstand up to 25 launderings.

“Social determinants of health such as race and income impact health outcomes – this is true here in Chicago, where COVID-19 case rates have been higher in minority, low-income areas,” said Karen Frey, Senior Philanthropy Manager, Medline. “Through this initiative, we continue our fight for health equity.”

Prior to the pandemic, people living in Chicago’s most vulnerable communities were already disproportionately impacted by social determinants of health. COVID-19 only exacerbates the problem, especially for those not adequately protected. Recent research from the Chicago Urban League finds that Black residents account for 30% of Chicago’s population but 54% of the city’s coronavirus deaths. The organizations involved share a sense of purpose to provide Black and Brown Chicagoans access to basic necessities in order to live safe and healthy lives, regardless of their circumstances. Today, it is simply a reusable mask. Now more than ever, the well-being of our communities is the top priority.

The partnership included distribution through community organizations that partner with Blue Cross and Blue Shield of Illinois and the YMCA’s Chicagoland locations.

“This horrible virus is tricky, and families need to protect themselves. It is during challenging times like these when market-wide nonprofits such as the YMCA of Metropolitan Chicago should leverage their depth, reach, and networks to partner with other community groups doing great work. We are proud to be a part of such a practical collaboration that may help lessen the anxiety for local families,” said Richard Malone, President and CEO, YMCA of Metropolitan Chicago.

Blue Cross and Blue Shield of Illinois has been working since the start of the pandemic to support its members and communities most impacted by the emerging health, economic and social impacts of COVID-19, including providing 150,000 masks for providers and $1.5M in grants to community organizations focused on hunger, shelter and access to care.

“Wearing a facemask is a key to stopping the spread of COVID-19 based on CDC prevention recommendation and we’re proud to be able to be part of this Project to bring hands-on help to some of the neighborhoods most impacted by COVID-19,” said Harmony Harington, VP Government, Communications and Community Relations for Blue Cross and Blue Shield of Illinois. “We believe these wash and rewear masks can help make a longer-term impact on not just the people receiving them, but everyone they come in contact with.”

Knowality is a venture services firm dedicated to accelerating the adoption of health care services that improve population health. By increasing the speed of market adoption for proven health care services, Knowality is increasing the likelihood of Americans living a healthy lifestyle.

“While it is important to focus on the front line healthcare worker, it is equally important to prioritize efforts upstream in the community,” said Dr. Trent Haywood, Founder and Chief Executive Officer for Knowality. “It is upstream where we will reduce exposure.”

Visit the Medline Newsroom for the full list of facemask distribution locations and times.

About Medline
Medline is a healthcare company: a manufacturer, distributor and solutions provider focused on improving the overall operating performance of healthcare. Medline works with both the country’s largest healthcare systems and independent facilities across the continuum of care to provide the clinical and supply chain resources required for long-term financial viability in delivering high quality care. With the size of one of the country’s largest companies and the agility of a family-owned business, Medline is able to invest in its customers for the long-term and rapidly respond with customized solutions. Headquartered in Northfield, Ill., Medline has 26,000+ employees worldwide, a fleet of nearly 1,000 trucks and does business in more than 90 countries. Learn more about Medline at www.medline.com.

About YMCA
The YMCA of Metro Chicago is an association of 14 Y centers, five overnight camps, and dozens of extension sites located in the city and across the suburbs. We serve more than 200,000 members annually and help children, families, and communities learn, grow, and thrive through programs that promote academic readiness, character development, violence prevention, and fitness and healthy living. Our impact is felt every day when an individual makes a healthy choice, when a mentor inspires a child, and when a community comes together for the common good. Learn about how the Y is working for a better us at ymcachicago.org

About Blue Cross and Blue Shield of Illinois
Blue Cross and Blue Shield of Illinois (BCBSIL) is committed to expanding access to quality, cost-effective health care to as many people as possible in Illinois. BCBSIL is dedicated to innovation and exploring, nurturing and activating future possibilities to make the health care system work better for our members and our communities. BCBSIL is a division of Health Care Service Corporation, a Mutual Legal Reserve Company and an Independent Licensee of the Blue Cross and Blue Shield Association.

About Knowality
Knowality, LLC., provides health care startups with network services, product strategy, contract support and advisory services to strategically target market opportunities with payers and providers. For more information, visit www.knowality.com

Healthcare Careers in 2020: An In-Demand Industry
Confident black doctor in healthcare face mask and gloves

Healthcare careers are part of the fastest growing industry for job growth and development in the United States. This trend is expected to continue over the next decade.

Projections from the U.S. Bureau of Labor Statistics (BLS) show that healthcare jobs are expected to increase by 18 percent from 2016 through 2026. This means that the industry will add about 2.4 million new healthcare jobs.

Why Healthcare?

There are several aspects that lead people to consider an exciting and rewarding career in healthcare. From potential financial reward and a diverse environment to career growth and personal fulfillment, there’s plenty of opportunities available and reasons to enter the field.

Healthcare Industries

Healthcare is a wide-spanning industry encompassing a variety of jobs. The profession is no longer tied to some of the more traditional positions in doctors’ offices or hospitals. In fact, the last two decades have seen an eruption in non-doctor roles. Today, healthcare providers are also needed in less mainstream sectors such as marketing, tech positions and more.

Healthcare Career Shortages in the U.S.

This field will add more employees than any other occupation in the coming years, according to the BLS. This is largely due to the accessibility of healthcare and the aging baby boomer generation.

Most recently, retired doctors, nurses and other medical professionals have been recruited and asked to return work to help provide medical attention to patients infected with Covid-19 virus. The US was projected to face a shortage of doctors before the pandemic hit: The Association of American Medical Colleges had estimated that it could reach 46,900 to 121,900 physicians by 2032. And in rural areas, particularly in states such as Mississippi and Arkansas, doctors were already in short supply. Many states are also projected to face significant nursing shortages in the coming years, particularly California and Texas.

Accordingly, the Bureau of Labor Statistics has forecast that healthcare job opportunities will continue to soar through 2025.

Top 10 Medical Careers in Demand For 2020 and Beyond:


Registered Nurses (RN’s)

Physical Therapists

Occupational Therapists

Respiratory Therapists

Home Health Aides

Medical Assistant

Physician Assistant

Healthcare Information Technologist

Pharmacy Technician

An Industry Full of Opportunity

Choosing a lasting, profitable, fulfilling career that you can be satisfied with means choosing a profession in healthcare. Many career benefits of healthcare include improving the lives of others and making a difference. The financial benefits, tremendous growth and high paying careers are limitless. It’s never too late to pursue a career in the medical field.

Source: https://medbrainmedia.com, U.S. Bureau of Labor Statistics, gmercyu.edu

Dr. Sanjay Gupta: A Beacon of Truth in a Storm of Misinformation
Dr. Gupta

By Jaeson Parsons

Public health has never been more critical and those in this field have become increasingly important as the coronavirus crisis continues to rage across the nation and around the world. Hunkering down due to stay-at-home orders, Americans are seeking advice as to how to cope, and Dr. Sanjay Gupta is one of the clear standouts in this fight against unseen enemies, the coronavirus and the misinformation surrounding it.

From the tragedies of 9/11 to the Gulf of Mexico oil spill in 2010, Dr. Gupta has a long and prestigious history of credible work within the healthcare and media industry as both a respected neurosurgeon and as a medical correspondent on CNN.

Most recently, Dr. Gupta has been advising those concerned about the realities of COVID-19 through his regular podcast, entitled, Coronavirus: Fact vs. Fiction. He interviews experts in healthcare and policy to provide useful, credible information to combat the influx of misinformation which has become rampant during this ongoing national emergency.

Dr. Gupta also spends his days at Emory University Hospitals with his colleagues helping to present facts to a nation inundated by information from all sides. His latest work includes antibody testing—which was administered to him personally— and describing what he learned from the process.

Dr. Gupta performing surgery
Dr. Sanjay Gupta and a Navy surgeon perform surgery on a 12-year-old Haitian girl with a severe head injury. (Photo by U.S. Navy via Getty Images)

“There are two different tests we are all becoming familiar with,” he says. “A diagnostic test that searches for the genetic markers of the Coronavirus and one that tests for antibodies.”

Dr. Gupta had his own blood taken to a lab to determine whether he was exposed to the virus, and then used his platform on CNN to showcase how this is done. He showed each step through the eyes of the experts he often speaks with, including Dr. Fauci, the national director for the National Institute of Allergy and Infectious Diseases (NIAID)—a name the nation has become familiar with over the last few months. On his Twitter profile, Dr. Gupta recites his interactions with individuals such as Dr. Fauci to provide additional insight on the outbreak, stating, “There is still so much we don’t know about how the [Corona] virus works and impacts our bodies.”

The Quest for a Vaccine

In another podcast episode, Dr. Gupta reviewed the latest developments for the much-needed COVID-19 vaccine.

“The search for a vaccine has become one of the fastest moving in history,” said Dr. Gupta during his interview with medical student Sean Doyle, who is one of several clinical participants in a vaccine trial.

Doyle received his first dose of the vaccine in March at Emory University Hospital where Dr. Gupta is on the faculty as a neurosurgeon. Since receiving it, Doyle has returned each week, giving blood samples so vaccine investigators can monitor his health and the effectiveness of the trial.

“People like Sean are the only way vaccines can be proven effective for the population at large,” Dr. Gupta said. “While there are unknown risks for the early trial volunteers, it would be even riskier to skip these important testing stages.”

He highlighted these risks by giving the Swine Flu vaccination program during the Ford Administration as an example. In 1976, the US feared a pandemic and the vaccine was rushed to the public.

“In less than a year, nearly 25 percent of Americans had been vaccinated,” he said. “But soon, devastating side effects began to emerge. At least 30 people died after receiving the vaccine and about 450 more developed Gian Beret Syndrome, a neurological disorder which can lead to paralysis. The program was ended and lawsuits flooded the government.”

The Late Show with Stephen Colbert and guest Dr. Sanjay Gupta during Thursday's March 12, 2020 show.
The Late Show with Stephen Colbert and guest Dr. Sanjay Gupta during Thursday’s March 12, 2020 show. (Photo by Scott Kowalchyk/CBS via Getty Images)

This is just one example of why vaccine trials are so critical and why podcasts such as Dr. Gupta’s are so important—to ensure the public understands the critical components the government and healthcare providers must follow in order to keep the public safe from hasty quick fixes.

On the Frontlines

Dr. Gupta grew up in a suburb outside of Detroit, Michigan. His parents both worked at the Ford Motor Company, with his mother being the first female engineer hired by Ford. Dr. Gupta earned both his undergraduate and his medical degree from the University of Michigan, and he performed his residency at the university hospital. He completed fellowships at the University of Michigan Medical Center and the University of Tennessee’s Semmes-Murphy Clinic. In addition, Dr. Gupta was selected as one of 15 White House Fellows, in 1997, serving as a healthcare speech writer and special advisor for First Lady Hillary Clinton.

In 2003, he was named one of People Magazine’s, “Sexiest Men Alive.” The following year, he married Atlanta family law attorney Rebecca Olson and together, they have three daughters—Soleil, Sage and Sky.

In addition to his medical pedigrees, Dr. Gupta has extensive experience in medical journalism.

Dr. Sanjay Gupta speaks during CNN's Dr. Sanjay Gupta "Cheating Death" Book Party in New York City.
Dr. Sanjay Gupta speaks during CNN’s Dr. Sanjay Gupta “Cheating Death” Book Party in New York City. (Photo by Jemal Countess/WireImage)

He publishes a column in Time Magazine and has written three books: Chasing Life, Cheating Death, and Monday Mornings: A Novel.

Dr. Gupta joined CNN as a medical correspondent in 2001, just months before the September 11th attacks, and reported from the wreckage at ground zero. He was on the frontlines, reporting the latest from the war. When the U.S. invaded Iraq in response to 9/11, Dr. Gupta embedded with the U.S. Navy’s “Devil Docs” medical unit, traveling from Kuwait to Baghdad, Iraq, providing live coverage. He also performed several life-saving brain surgeries in a combat hospital deep within the desert.

Essential Contributions

Dr. Gupta’s contributions have earned him many accolades, including his work covering the devastation of Hurricane Katrina in 2006, which earned CNN a Peabody Award. His coverage of the New Orleans Charity Hospital, which he revealed was not evacuated as previously thought, earned him an Emmy Award for Outstanding Feature Story.

He was also honored by the Atlanta Press Club, who named him Journalist of the Year for 2004, as well as for his work as a healthcare provider by the Health Communications Achievement Award from the American Medical Association.

Dr. Sanjay Gupta And Family Visit Walt Disney World Resort
Dr. Sanjay Gupta and Family Visit Walt Disney World Resort(Photo by Ryan Wendler/Disney Parks via Getty Images)

In addition to informing the adult population on the coronavirus crisis, Dr. Gupta recently hosted a town hall meeting focused on children and their concerns. He worked in partnership with Sesame Street and CNN to develop the, “ABC’s of COVID-19: A CNN/Sesame Street Town Hall for Kids and Parents,” which tackled issues important to kids and their parents.

Explaining how the virus has become a pandemic, Dr. Gupta reassured children there was no reason to panic, because “Scientists, doctors, and nurses all over the world are working hard to help.”

Along with his nightly updates on the progression of the virus and continued developments of a life-saving vaccine, Dr. Gupta continues to provide insight through many outlets such as social media and his podcasts, reassuring both child and adult alike that humanity can and will overcome this invisible enemy.

“We don’t know when it’s going to be over—I wish we did, but that’s the honest answer,” he said. “But it is going to be over. It’s not going to last forever.”

Air Force Civilian Service

Air Force Civilian Service



Upcoming Events

  1. Commercial UAV Expo Americas, Las Vegas
    September 7, 2021 - September 9, 2021
  2. Wonder Women Tech
    October 26, 2021 - October 29, 2021
  3. AEC Next Technology Expo & Conference, International Lidar Mapping Forum, and SPAR 3D Expo & Conference
    February 6, 2022 - February 8, 2022

Upcoming Events

  1. Commercial UAV Expo Americas, Las Vegas
    September 7, 2021 - September 9, 2021
  2. Wonder Women Tech
    October 26, 2021 - October 29, 2021
  3. AEC Next Technology Expo & Conference, International Lidar Mapping Forum, and SPAR 3D Expo & Conference
    February 6, 2022 - February 8, 2022